NovoCure Ltd (MEX:NVCR)
MXN 275.39 0 (0%) Market Cap: 37.39 Bil Enterprise Value: 31.76 Bil PE Ratio: 0 PB Ratio: 5.23 GF Score: 69/100

Q3 2021 Novocure Ltd Earnings Call Transcript

Oct 28, 2021 / 12:00PM GMT
Operator

Good day, ladies and gentlemen, and welcome to NovoCure's Third Quarter 2021 Earnings Conference Call. (Operator Instructions) As a reminder, this call is being recorded. (Operator Instructions)

I would now like to turn the call over to your host today, Ingrid Goldberg, Vice President of Finance and Investor Relations. Please go ahead.

Ingrid Goldberg

Good morning, everyone, and thank you for joining us to review NovoCure's third quarter 2021 performance. I'm joined on the phone by our Executive Chairman, Bill Doyle; our CEO, Asaf Danziger; and our CFO, Ashley Cordova. Other members of the executive leadership team are also on the call and available for Q&A.

The slides presented today can be view on our website, www.novocure.com, by clicking on the link for the third quarter 2021 financial results located in the Event section of our Investor Relations page.

Before I start, I would like to remind you that our discussions during this conference call will include forward

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot